1Grant SS. Options for Down Syndrome Screening: What Will Women Choose? [J]. J Midwifery Womens Health,2005,50(3) :211 -8.
2Rosen T, D'Alton ME. Down Syndrome Screening in the First and Second Trimesters: What Do the Data Show? [ J ]. Semin Perinatol, 2005,29(6) :367 -75.
3Lambert- Messerlian GM, Canick JA. Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome [ J]. Semin Reprod Med,2004,22(3) :235 -42.
4Palomaki GE, Lambert -Messerlian GM,Canick JA. A summary analysis of Down syndrome markers in the late first trimester[J]. Adv Clin Chem,2007,43 : 177 - 210.
5Laigaard J,Spencer K,Christiansen M,et al. ADAM 12 as a first - trimester maternal serum marker in screening for Down syndrome[ J]. Prenat Diagn,2006,26(10) :973 -9.
6Scott A. Nuchal translucency measurement in first trimester Down syndrome screening [ J ]. Issues Emerg Health Technol,2007, ( 100 ) : 1-6.
7Falcon O,Auer M,Gerovassili A,et al. Screening for trisemy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks[J]. Ultrasound Obstet Gyneco1,2006,27 (2) : 151 - 5.
8Fuchs KM, Peipert JF. First trimester Down syndrome screening: public health implications[ J]. Semin Perinatol,2005,29 (4) :267 - 71.
9Wenstrom KD. Evaluation of Down syndrome screening strategies [J]. Semin Perinatol,2005,29(4) :219 -24.
9Wald N J, Rodeck C, Hackshaw AK, et al. First and second trimester antennal screening for Down's syndrome:the results of the serum,urine and ultrasound screening study (SURUSS)[J]. J Med Screen, 2003, 10(2):56-104.
10Summers AM, Farrell SA, Huang T, et al. Maternal serum screening in ontario using the triple marker test [J].J Med Screen, 2003,10(3) ; 107-111.
